Advertisement
Advertisement
IBIO
iBio, Inc. Common Stock
2.10
USDSponsored
-0.09
-4.11%
Apr 15, 15:59 UTC -4
Closed
After-Market
2.17
+0.07
+3.57%
IBIO Earnings Reports
Positive Surprise Ratio
IBIO beat 7 of 18 last estimates.
39%
Next Report
Date of Next Report
Apr 30, 2026
Estimate for Q3 26 (Revenue/ EPS)
$20.40K
/-$0.06
Implied change from Q2 26 (Revenue/ EPS)
--
/-33.33%
Implied change from Q3 25 (Revenue/ EPS)
--
/-87.76%
iBio, Inc. Common Stock earnings per share and revenue
On Feb 10, 2026, IBIO reported earnings of -0.09 USD per share (EPS) for Q2 26, missing the estimate of -0.08 USD, resulting in a -6.89% surprise. Revenue reached --, compared to an expected 34.00 thousand, with a -100.00% difference. The market reacted with a -2.64% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 20.40 thousand USD, implying an decrease of -33.33% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Pharvaris N.V. Ordinary Shares
Report Date
Apr 02, 2026 For Q4 25
Estimate
-$0.63
Actual
-$0.72
Surprise
-13.69%
Nurix Therapeutics, Inc. Common stock
Report Date
Apr 08, 2026 For Q1 26
Estimate
-$0.76
Actual
-$0.79
Surprise
-2.68%
NovaBridge Biosciences - ADR
Report Date
Apr 07, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.28
Surprise
-421.58%
Scilex Holding Company Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$0.47
Actual
-$2.21
Surprise
-360.99%
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Quince Therapeutics, Inc. Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$1.92
Actual
-$7.10
Surprise
-268.68%
Sunshine Biopharma Inc.
Report Date
Apr 03, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.54
Surprise
-96.08%
FAQ
What were iBio, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, iBio, Inc. Common Stock reported EPS of -$0.09, missing estimates by -6.89%, and revenue of $0.00, -100% below expectations.
How did the market react to iBio, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -2.64%, changed from $2.27 before the earnings release to $2.21 the day after.
When is iBio, Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 30, 2026.
What are the forecasts for iBio, Inc. Common Stock's next earnings report?
Based on 6
analysts, iBio, Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $20.40K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement